Antibody expression in mammalian cells is an ever increasing need in drugdiscovery and in the development of new diagnostics. Our role at Magellan Biologics & Consulting is to make it accessible, simple and efficient.
A reliable host cell line, a good laminar flow hood, a dedicated shaker-incubator, some vented bioreactor tubes or erlenmeyers,
micropipettes, usual lab consumables and our CHO4Tx® kit is all you need to express your DNA sequences in 7 to 14 days.
👉 We at Magellan Biologics & Consulting proudly support the scientificcommunity in their R&D projects through our CHO4Tx® product portfolio that allows in-house, fast, easy and efficient transient proteinexpression in CHO cells and through personalized advices and consultancies.
A novel drug produced in CHO cells has recently been approved by the FDA
Tislelizumab-jsgr is a PD-1 blocking antibody indicated for the treatment of adult patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) after prior systemic
29 March 2024
